Summit Securities Group
TEVA icon

Summit Securities Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Summit Securities Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Sell
7,000
-500
-7% -$16.7K 0.02% 251
2026
Q1 		$226K Buy
7,500
+1,500
+25% +$48.3K 0.03% 220
2025
Q4 		$187K Buy
6,000
+2,031
+51% +$50K 0.02% 345
2025
Q3 		$80.2K Buy
+3,969
New +$69.7K 0.02% 434
2024
Q3 		– Sell
-22,500
Closed -$366K – 855
2024
Q2 		$366K Buy
+22,500
New +$347K 0.07% 123
2016
Q1 		– Sell
-8,200
Closed -$538K – 326
2015
Q4 		$538K Buy
8,200
+2,900
+55% +$179K 0.17% 87
2015
Q3 		$299K Buy
5,300
+2,900
+121% +$188K 0.22% 62
2015
Q2 		$142K Buy
2,400
+100
+4% +$6.17K 0.07% 97
2015
Q1 		$143K Sell
2,300
-23,400
-91% -$1.36M 0.11% 104
2014
Q4 		$1.48M Sell
25,700
-13,100
-34% -$730K 0.42% 50
2014
Q3 		$2.09M Buy
38,800
+36,500
+1,587% +$1.93M 0.6% 44
2014
Q2 		$121K Buy
2,300
+1,800
+360% +$92K 0.04% 212
2014
Q1 		$26K Sell
500
-22,100
-98% -$1.02M 0.02% 221
2013
Q4 		$906K Sell
22,600
-10,800
-32% -$425K 0.16% 75
2013
Q3 		$1.26M Buy
33,400
+10,300
+45% +$402K 0.43% 38
2013
Q2 		$906K Buy
+23,100
New +$900K 0.43% 46

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Summit Securities Group's TEVA Position: Q2 2026 in Review

Summit Securities Group reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 6.7% in Q2 2026, selling an estimated $16.7K and leaving 7,000 shares worth $237K. The position accounts for 0.02% of the portfolio, ranked #251.

Summit Securities Group first reported a position in TEVA in Q2 2013 and has held it in 16 quarters since. The position peaked at $2.09M in Q3 2014. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Summit Securities Group held 7,000 shares of Teva Pharmaceutical Industries Limited worth $237K as of Q2 2026.
  • Summit Securities Group sold 500 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $16.7K.
  • Teva Pharmaceutical Industries Limited made up 0.02% of Summit Securities Group's portfolio in Q2 2026, its #251 holding.
  • Summit Securities Group first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 16 quarters since.
  • Summit Securities Group's Teva Pharmaceutical Industries Limited position peaked at $2.09M in Q3 2014.
  • 677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.